Article

5 Must-See Sessions for Specialty Pharmacists at ASHP Midyear 2018

The American Society of Health-System Pharmacists (ASHP) kicked off its annual Midyear Clinical Meeting and Exhibition this Saturday in Anaheim, California.

The American Society of Health-System Pharmacists (ASHP) kicked off its annual Midyear Clinical Meeting and Exhibition this Saturday in Anaheim, California.

Each year, more than 25,000 pharmacy professionals from around the world attend the meeting, which provides valuable opportunities for professional development, enhancing practice skills, and staying up-to-date on the latest products and innovations.

Specialty pharmacists can gain valuable information from ASHP’s new Section of Specialty Pharmacy Practitioners (SSPP), which provides an enhanced focus on helping its members provide optimal patient care and comprehensive medication management in the specialty pharmacy environment in hospitals and health systems. The SSPP offers broad range of education, tools, resources, strategies initiatives, professional policies, and advocacy to support specialty pharmacists. More information can be found here.

Here are some of the sessions you’ll be able to watch for in our coverage:

1. Opening Session

To formally kick off Midyear, the opening session featured a keynote address by retired basketball legend Magic Johnson, who shared his story as an HIV/AIDS advocate. Read our coverage of his speech here.

2. Biosimilars in Supportive and Therapeutic Cancer Care: Key Issues and Considerations for Pharmacists

This session provides an overview of biologics and regulatory review, as well as operational considerations and value proposition for the use of biosimilars in cancer care within the health system. Read more here.

3. Winning or Losing? Challenges with Operationalizing Biosimilar Reimbursement

In this educational session, topics include challenges facing biosimilar reimbursement, strategies to manage payer mandates, and actionable steps that pharmacy leadership can take to operationalize changes to formulary management in response to reimbursement shifts.

4. Evolving Role of Immunotherapy in Cancer Treatment

This activity will explore the evolving issues, key questions, and controversies associated with the use of immunotherapies for the treatment of patients with both solid tumor and hematologic malignancies.

5. Results from the 2018 ASHP National Survey: The Current State of Pharmacy Practice in Hospitals and Health Systems

Want to know more about what health system pharmacists think about the state of pharmacy practice? This session will outline the results of the 2018 ASHP National Survey and describe how these results can be used to effect change in health systems.

Specialty Pharmacy Times® will be onsite throughout the conference bringing you live updates, interviews, and more. Check in with our daily e-newsletter and follow our coverage on social media with #ASHP18.

Related Videos
MARIPOSA Study: Long-Term Outcomes and Next Steps for Amivantamab Plus Lazertinib in EGFR-Mutant NSCLC
The EMPOWER-Lung 1 Trial: Five-Year Outcomes of Cemiplimab Monotherapy in Advanced NSCLC
October is American Pharmacists Month.
smiling indian male doctor or pharmacist in white coat with stethoscope and clipboard over drugstore background